GL1X · GenesisL1 explorer

MolNFT v1 · #131284 · protein

Ligand binding to farnesoid-X-receptor

5Q0N · Bile acid receptor: “Ligand binding to farnesoid-X-receptor”. X-ray diffraction, 1 ligand (9L4), 6 pockets (best druggability 0.85). MolNFT v1 #131284 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5Q0N
Type
protein
Length
479 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bile acid receptor; Coactivator peptide src-1 HD3
UniProt
Q96RI1, A8K1V4
Ligands
9L4
Pockets
6 · best druggability 0.85

Structure

x-ray diffraction · 4 distinct chains · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABile acid receptorprotein22971% helix, 0% strandQ96RI1
BCoactivator peptide src-1 HD3protein1173% helix, 0% strandA8K1V4
CBile acid receptorprotein22872% helix, 0% strandQ96RI1
DCoactivator peptide src-1 HD3protein1173% helix, 0% strandA8K1V4

Ligands and binding sites

  • 9L4 · 3-chloro-4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid · ligand · 2 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13610.850.94379L4
23920.850.93439L4
31560.460.7723empty
41080.410.7716empty
5780.350.7620empty

Interfaces

3 interfaces between chains.

  • C–D · 612 Ų buried · 10 hydrogen bonds · protein-protein
  • A–B · 606 Ų buried · 6 hydrogen bonds · protein-protein
  • A–C · 179 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 5Q0N · Ligand binding to FARNESOID-X-RECEPTOR · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.